Circulating Tumor Cell (CTC) Diagnostics Market Size, Share, and Growth 2022-2028
Circulating Tumor Cell (CTC) Diagnostics Market: Strategic Insights
Circulating Tumor Cell (CTC) Diagnostics Market
-
CAGR (2021 - 2028)9.7% -
Market Size 2021
US$ 1.91 Billion -
Market Size 2028
US$ 3.66 Billion
Market Dynamics
GROWTH DRIVERS
- Rising cancer prevalence worldwide
- Increased demand for non-invasive diagnostics
- Advancements in CTC detection technologies
FUTURE TRENDS
- Use of microfluidics in CTC isolation
- Increased focus on predictive analytics
- Integration with next-generation sequencing
OPPORTUNITIES
- Expansion in liquid biopsy applications
- Development of AI-driven diagnostics
- Growth in personalized cancer treatments
Key Players
- Thermo Fisher Scientific Inc
- STEMCELL Technologies Inc
- QIAGEN
- Precision Medicine Group LLC
- Advanced Cell Diagnostics Inc BIO TECHNE CORPORATION
- Epic Sciences
- ScreenCell
- Ikonisys Inc
- IVDiagnostics
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Technology
- CTC Detection and Enrichment Method
- CTC Direct Detection Methods
- CTC Analysis
Application
- Clinical/Liquid Biopsy and Research
End User
- Hospital and Clinics
- Research and Academic Institutes
- Diagnostic Centers